Stage
Corporate Minority | AliveMissing: GRAFTcath's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: GRAFTcath's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
GRAFTcath Frequently Asked Questions (FAQ)
What is GRAFTcath's latest funding round?
GRAFTcath's latest funding round is Corporate Minority.
Who are the investors of GRAFTcath?
Investors of GRAFTcath include Boston Scientific Ventures and Cutlass Capital.
Who are GRAFTcath's competitors?
Competitors of GRAFTcath include MedShape, Respicardia, Access Scientific, Vascular Pathways, arstasis and 12 more.
Compare GRAFTcath to Competitors
Hemosphere (formerly GRAFTcath) has developed a vascular access product that has the potential to reduce the risk of bacteremia, or severe infection, posed to catheter-dependent patients undergoing hemodialysis.
ExploraMed is a medical technology incubation company dedicated to the identification, creation and development of medical device solutions. ExploraMed creates ideas in the fields of clinical, engineering, legal, strategic marketing, and financing, while focusing on efficient and timely development.
Claros Diagnostics is an early stage device company developing a POC multiplex diagnostic focused on a biomarker panel for prostate cancer.
a medical device company, based in part on intellectual property of CardioVascular Technologies, Inc. (http://cvtechinc.com), and is focused on the development and commercialization of the vascular access closure technology for the Interventional Cardiology market. The company is comprised of several seasoned medical device professionals and physicians, with a proven record of innovation, clinical acumen, access to the industry and successful commercialization of multiple medical device technologies.
Primaeva Medical is an early stage medical device company developing a skin tightening and rejuvenation dermatological device
Endothelix, Inc. is a cardiovascular device company focused on addressing inaccurate individualized prediction of cardiovascular risk and inadequate monitoring of the vascular response to treatments.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.